SCHEMBL6942491

SCHEMBL6942491

CCOc1ccccc1N/C=C1\C(=O)N(c2ccc(S(=O)(=O)NC(C)=O)cc2)N=C1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.47
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 3/20 0.42
MDM4 O15151 1/20 0.42
MDM2 Q00987 1/20 0.42
KAT8 Q9H7Z6 3/20 0.40
MAPT P10636 3/20 0.40
GAA P10253 3/20 0.40
MEN1 O00255 2/20 0.40
CYP1A2 P05177 2/20 0.40
THRB P10828 2/20 0.40
CYP2C9 P11712 2/20 0.40
HPGD P15428 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942495 1.00 PTGS2 (0.47) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL8009451 0.88 PTGS2 (0.47) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL6951766 0.88 PTGS2 (0.47) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL6950421 0.86 PTGS2 (0.60) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL6950419 0.86 PTGS2 (0.60) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL9525776 0.85 ALDH1A1 (0.53) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL6949544 0.84 PTGS2 (0.47) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL6949542 0.84 PTGS2 (0.47) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL8428159 0.84 PTGS2 (0.46) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E
SCHEMBL8427561 0.82 PTGS2 (0.56) PTGS2ALDH1A1KMT2AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed